Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
Intest Res
.
2017 Jul;15(3):263-265.
doi: 10.5217/ir.2017.15.3.263.
Epub 2017 Jun 12.
Authors
Jihye Park
1
,
Jae Hee Cheon
1
Affiliation
1
Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
PMID:
28670224
PMCID:
PMC5478752
DOI:
10.5217/ir.2017.15.3.263
No abstract available
Publication types
Editorial